Not all patients with CLL demand therapy. Irrespective of all new improvements, the iwCLL even now recommends watchful observation for people with asymptomatic disease.86 This advice is predicated on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).10… Read More